Hemothorax under thrombolytic therapy with recombinant tissue

Abstract

We present the case of a 16-year-old girl with an extended thrombosis of the femoral and iliac vein and the inferior vena cava during pleuropneumonia; predisposing risk factors for thrombophilia were: use of contraceptives, nicotine abuse and congenital deficiency of antithrombin III (not previously diagnosed). Thrombolytic therapy with recombinant tissue plasminogen activator (rt-PA; initial dose: 0.08 mg/kg/h) was started. 2 days later – after diagnosis of an extended hemothorax: 1500 ml blood were obtained after thoracocentesis, transfusion of packed red blood cells was necessary – rt-PA was stopped, with only heparin (400 U/kg/d) being administered. 36 h later – the thrombosis had not yet changed – the thrombolytic therapy with rt-PA was continued in a markedly reduced dose (0.015 mg/kg/d) with no further bleeding complications. 8 days later – after successful thrombolysis – rt-PA was stopped, heparin was given for another 10 days, then cumarin was administered orally.